Published/Hosted by BioCommunications LLC.
Discontinued in 2012. Biotechnology Healthcare reports on the how biopharmaceuticals and molecular diagnostics are managed and used, their value to third-party payers and employer purchasers, and how these audiences face the coverage, economic, and health policy issues biologics pose. We provide a forum for the discussion of these issues and how to overcome the challenges of providing appropriate access to biologics while keeping healthcare affordable. This publication is not, nor does it try to be, a scientific journal; rather, it is a guide to help decision makers understand what issues their peers are struggling with, how they are dealing with those issues, and how scientific advances shape trends and affect healthcare financing, utilization, and public policy.
- Further information
- Category Link